أرسل هذا في رسالة قصيرة: Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS study

__    __    ______    ______   __   __     _____  
\ \\ / //  /_   _//  /_____//  \ \\/ //   / ___// 
 \ \/ //    -| ||-   `____ `    \ ` //    \___ \\ 
  \  //     _| ||_   /___//      | ||     /    // 
   \//     /_____//  `__ `       |_||    /____//  
    `      `-----`   /_//        `-`'   `-----`   
                     `-`